Offer - Urjas Oil for just ₹ 1
Ultrorelix, a prescription drug, is manufactured in various forms such as Injection. It is typically used for the treatment of Female Infertility.
The right dosage of Ultrorelix depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Ultrorelix are Injection Site Allergic Reaction, Itching or burning. While these are the most often observed Ultrorelix side effects, there are can be others also. These have been listed below. Normally, these side effects of Ultrorelix are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Ultrorelix's effect is Severe during pregnancy and Unknown for lactating mothers. In addition, Ultrorelix's effects on the liver, heart and kidney are discussed below in the Ultrorelix related warnings section.
Ultrorelix is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease are examples of such conditions. Some other conditions that can be affected by Ultrorelix are listed in the contraindications section below.
Additionally, Ultrorelix may also adversely react with other medicines. See below for a complete list.
You should also be aware that Ultrorelix is safe while driving, and is addiction.
Ultrorelix is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Is the use of Ultrorelix safe for pregnant women?
Ultrorelix can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Ultrorelix safe during breastfeeding?
No research work has been carried out till date on effect of Ultrorelix on breastfeeding women. So it is not known whether taking Ultrorelix will cause side effects or not.
What is the effect of Ultrorelix on the Kidneys?
There may be some adverse effects on kidney after taking Ultrorelix. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Ultrorelix on the Liver?
Ultrorelix may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Ultrorelix on the Heart?
Side effects of Ultrorelix rarely affect the heart.
Ultrorelix should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Ultrorelix unless your doctor advises you to do so -
Is this Ultrorelix habit forming or addictive?
Forming a habit of Ultrorelix has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Ultrorelix will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but take Ultrorelix only as per medical advice.
Is it able to treat mental disorders?
No, Ultrorelix is not used to treat mental disorders.
Interaction between Food and Ultrorelix
There isn't any research available on the side effects of taking Ultrorelix with food.
Interaction between Alcohol and Ultrorelix
Due to lack of research, there is no information about the side effects of taking Ultrorelix with alcohol.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cetrotide® (cetrorelix acetate for injection)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 243